Content - Preview
Preview of fully accepted papers, still not published in any volume
QUIZ
Hongmei Zhou, Qiang Zhao, Lihong Zhao, Qian Shang, Jing Li, Songmei Geng
Abstract is missing (Quiz)
SHORT COMMUNICATION
Cataldo Patruno, Maddalena Napolitano, Silvia Ferrucci, Lucia Brambilla, Katharina Hansel, Monica Corazza, Donatella Schena, Caterina Foti, Paolo Romita, Rosella Gallo, Luca Stingeni
Abstract is missing (Short communication)
CLINICAL REPORT
Lieneke F.M. Ariëns, Abhijit Gadkari, Harmieke van Os-Medendorp, Rajeev Ayyagari, Emi Terasawa, Andreas Kuznik, Zhen Chen, Gaëlle Bégo-Le Bagousse, Yufang Lu, Elena Rizova, Neil M.H. Graham, Gianluca Pirozzi, Marjolein De Bruin-Weller, Laurent Eckert
Dupilumab is approved for uncontrolled moderate-to-severe atopic dermatitis (AD), and cyclosporine for severe AD for ≤ 1 year. The efficacy/effectiveness of these treatments was compared indirectly. Regression models used pooled patient-level data to estimate response (Eczema Area and Severity Index (EASI) EASI-50/EASI-75 at weeks 12–16 and 24–30) to dupilumab 300 mg every 2 weeks (CHRONOS ...
SHORT COMMUNICATION
Clothilde Godillot, Maella Severino-Freire, Vincent Michaud, Franck Boralevi, Christine Labrèze, Vincent Guigonis , Giuliana Onnis, Fanny Morice-Picard, Juliette Mazereeuw-Hautier
Abstract is missing (Short communication)
QUIZ
Ferdinand Toberer, Martin Hartmann
Abstract is missing (Quiz)
CLINICAL REPORT
Gustav Boelsggard Christensen, Christian Ingvar, Linda Werner Hartman, Håkan Olsson, Kari Nielsen
The incidence of cutaneous squamous cell carcinoma has increased rapidly in Sweden in the past decades. Here, we present a prospective study of the Melanoma in Southern Sweden (MISS)-cohort, with 29,460 participating women in southern Sweden that investigates the risk factors for cutaneous squamous cell carcinoma. Data on the host and skin cancer risk factors were collected through questionnaires ...
SHORT COMMUNICATION
Anders D. Andersen, Alexander Almegaard, Anders Nikolai Ørsted Schultz, John Robert Zibert
Abstract is missing (short communication)
SHORT COMMUNICATION
Xian-hong Yang, Lin Lin, Jian-fang Sun, Yi-qun Jiang
Abstract is missing (Short communication)
SHORT COMMUNICATION
Eugenia Agut-Busquet, Iris González-Villanueva, Jorge Romani de Gabriel , Jose Carlos Pascual, Miquel Ribera Pibernat, Jesús Luelmo
Abstract is missing (Short communication)
SHORT COMMUNICATION
Gil Yosipovitch, Jennifer Soung, Jonathan Weiss, Elisa Muscianisi, Xiangyi Meng, Isabelle Gilloteau, Boni E. Elewski
Abstract is missing (Short communication)
CLINICAL REPORT
Svetlana Vakkilainen, Laura Puhakka, Paula Klemetti, Kaarina Heiskanen, Mikko Seppänen, Mikko Muona, Celine Posseme, Duffy Darragh, Timo Väisänen, Outi Elomaa, Maarit Palomäki, Harri Saxén, Annamari Ranki, Katariina Hannula-Jouppi
Desmoplakin (DSP) and Desmoglein 1 (DSG1) variants result in skin barrier defects leading to erythroderma, palmoplantar keratoderma and variable [AQ4] other features. Some DSG1 variant carriers present with SAM syndrome (Severe dermatitis, multiple Allergies, Metabolic wasting) and a SAM-like phenotype has been reported in 4 subjects with different heterozygous DSP variants. We report here a patie ...
QUIZ
Yue-Tong Qian, Jin-Yuan Ma, Sergio Vano-Galvan, Jia-Wei Liu, Wei Liu, Dong-Lai Ma
Abstract is missing (Quiz)
CLINICAL REPORT
Lieneke F.M. Ariëns, Kirsten J.M. van Nimwegen, Marjan Shams, Digna T. de Bruin, Jorien van der Schaft, Harmieke van Os-Medendorp, Marjolein De Bruin-Weller
Given the introduction of new therapies targeting specific immune pathways for atopic dermatitis (AD), information on the economic burden of AD patients is needed. Direct costs (medication use and healthcare resource utilization) and costs of productivity loss were studied in 90 adult patients with AD indicated for systemic treatment. Costs were calculated for patients with controlled (Investigato ...
QUIZ
Hiroyuki Irie, Teruki Dainichi, Yo Kaku, Kenji Kabashima
Abstract is missing (Quiz)
CLINICAL REPORT
Linda Tizek, Maximilian C. Schielein, Melvin Rüth, Rolf-Markus Szeimies, Wolfgang G. Philipp-Dormston, Stephan A. Braun, Christine Hecker, Bernadette Eberlein, Tilo Biedermann, Alexander Zink
Skin cancer is a major public health issue, which could be reduced through prevention programmes. However, prevention utilization is not very prevalent. It is therefore important to understand individuals’ interest in skin cancer. Google AdWords Keyword Planner was used to identify the search volume of terms relating to skin cancer in 9 German cities between July 2014 and June 2018. From a tot ...
CLINICAL REPORT
Eric L. Simpson, Gil Yosipovitch, Andrew G. Bushmakin, Joseph C. Cappelleri, Thomas Luger, Sonja Ständer, Wynnis L. Tom, William C. Ports, Michael A. Zielinski, Anna M. Tallman, Huaming Tan, Robert A. Gerber
Crisaborole ointment is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild to moderate atopic dermatitis. Using pooled data from two phase 3 studies (NCT02118766/NCT02118792), mediation modeling determined the interrelationship among pruritus, quality of life (QoL), and treatment. Patients aged ≥ 2 years received crisaborole ointment 2% or vehicle twice daily for 28 days. Q ...
SHORT COMMUNICATION
Liliana Guerra, Monia Magliozzi, Anwar Baban, Corrado Di Mambro, Giovanni Di Zenzo, Antonio Novelli, May El Hachem, Giovanna Zambruno, Daniele Castiglia
Abstract is missing (short communication)
CLINICAL REPORT
Pascal Del Giudice, Sophie Hakimi, Frédéric Vandenbos, Catherine Magana, Thomas Hubiche
Cutaneous larva migrans is a dermatitis, typically acquired in warm tropical or sub-tropical countries, caused by migration of the larvae of nematodes (hookworm; mainly Ancylostoma braziliense and, occasionally, Ancylostoma caninum or Uncinaria stenocephala), which are parasitic on animals such as cats and dogs, into the patient’s skin. The larvae penetrate the skin after contact with infected s ...
QUIZ
Iwona Chlebicka, Aleksandra Stefaniak, Zdzisław Woźniak, Jacek C. Szepietowski
Abstract is missing (Quiz)
SHORT COMMUNICATION
Roberta Rotunno, Andrea Diociaiuti, Rita De Vito, Stefania Gaspari, Claudia Carnevale, Simona Giancristoforo, May El Hachem
Abstract is missing (Short communication)
CLINICAL REPORT
Alicia Barreiro-Capurro, José Manuel Mascaró, Beatriz Alejo Galindo, Priscila Giavedoni, Cristina Carrera, Llucia Alos, Susana Puig, Josep Malvehy
Patients treated with haematopoietic stem cell transplantation are at increased risk of cutaneous malignant neoplasms. There are no reports on the characteristics of melanocytic lesions in patients with chronic graft versus host disease and the value of recognizing these difficult lesions in high-risk patients. The objective of this study is to describe the clinical and dermoscopic characteristics ...
CLINICAL REPORT
Shany Sherman, Efrat Solomon Cohen, Iris Amitay-Laish, Emmilia Hodak, Lev Pavlovsky
Interleukin-17A inhibitors are a promising alternative to tumor necrosis factor-α inhibitors for the treatment of psoriasis. In-class switch has been hardly investigated for interleukin-17A inhibitors. We report the experience (2017–2018) of a tertiary medical center with interleukin-17A-inhibitor switch in patients with moderate-to-severe psoriasis. Patient-, disease- and outcome-related data ...
INVESTIGATIVE REPORT
Vinciane Le Bris, Myriam Chastaing, Martine Schollhammer, Emilie Brenaut, Laurent Misery
Primary burning mouth syndrome is a term used for chronic oral mucosal pain with no identifiable organic cause. The aim of the study was to evaluate the usefulness of a psychiatric intervention for treating burning mouth syndrome based on a joint consultation with a psychiatrist and a dermatologist. The study was proposed to all patients who visited this consultation group between 2001 and 2017 fo ...
SHORT COMMUNICATION
Hiromitsu Noguchi, Tadahiko Matsumoto, Masataro Hiruma, Utako Kimura, Takashi Yaguchi, Miki Hirose, Satoshi Fukushima, Hironobu Ihn
Abstract is missing (short communication)
QUIZ
Marianela Ackerman, Annabel Maruani, Eric Estève, Remy Kerdraon, Antoine Finon
Abstract is missing (Quiz)
INVESTIGATIVE REPORT
Yuki Shono, Hiraku Suga, Hiroaki Kamijo, Hikari Fujii, Tomonori Oka, Tomomitsu Miyagaki, Naomi Shishido-Takahashi, Makoto Sugaya, Shinichi Sato
Tumor cells in cutaneous T-cell lymphoma express limited numbers of chemokine receptors. We investigated the expression patterns of CXCR3, CCR3, CCR4 and CCR10 in mycosis fungoides, Sézary syndrome, lymphomatoid papulosis and anaplastic large cell lymphoma in 121 skin biopsy samples. CXCR3 was expressed in 86% of mycosis fungoides cases but in no anaplastic large cell lymphoma cases. CCR3 was e ...
SHORT COMMUNICATION
Takahito Chiba, Takuya Nagai, Shin-ichi Osada, Motomu Manabe
Abstract is missing (short communication)
SHORT COMMUNICATION
Chika Ohata, Takekuni Nakama
Abstract is missing (short communication)
QUIZ
Gloria Orlando, Giovanna Dan, Serena Pezzetta, Dennis Linder, Roberto Salmaso
Abstract is missing (Quiz)
SHORT COMMUNICATION
Ayano Watanabe, Masazumi Onishi, Kanako Tsunoda, Hiroo Amano
Abstract is missing (Short communication)
SHORT COMMUNICATION
Andrea Diociaiuti, Adriano Angioni, Elisa Pisaneschi, Maria Margollicci, Renata Boldrini, Viola Alesi, Antonio Novelli, Giovanna Zambruno, May El Hachem
Abstract is missing (Short communication)
SHORT COMMUNICATION
Hiraku Kokubu, Hiroaki Ida, Toshihiro Tanaka, Noriki Fujimoto
Abstract is missing (Short communication)
CLINICAL REPORT
Petra Mauritz, Marcel F. Jonkman, Sanne S. Visser, Catrin Finkenauer, José C. Duipmans, Mariët Hagedoorn
Epidermolysis bullosa (EB) is a group of rare inherited bullous skin disorders that differ in nature and severity. Currently, there is no cure for the disease. One of the complex problems of EB is the repetitive and painful care of skin wounds. The purpose of this study was to explore how adult patients and parents experienced the impact of wound care during childhood and which coping strategies t ...
CLINICAL REPORT
Kentaro Yonekura, Koichiro Takeda, Nobuyo Kawakami, Tamotsu Kanzaki, Takuro Kanekura, Atae Utsunomiya
Cutaneous-type adult T-cell leukemia-lymphoma is treated with antiviral or skin-directed therapy. Medications that are used to treat skin lesions of cutaneous T-cell lymphomas are also used for the cutaneous-type adult T-cell leukemia-lymphoma. Etretinate, a synthetic retinoid, has been used for treating cutaneous T-cell lymphomas; however, its clinical effectiveness for the treatment of cutaneous ...
ERRATUM
Abstract is missing (Erratum)
BOOK REVIEW
Lisa Naysmith
Abstract is missing (Book review)
BOOK REVIEW
Jonathan Rees
Abstract is missing (Book review)
BOOK REVIEW
Anders Vahlquist
Abstract is missing (Book review)
BOOK REVIEW
Olle Larkö
Abstract is missing (Book review)
IN THIS ISSUE
Pavel V. Chernyshov
Abstract is missing (In this Issue...)
IN THIS ISSUE
Magnus Lindberg
Abstract is missing (In this Issue...)
INDEX
